UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Annals of surgical oncology, 2022-05, Vol.29 (5), p.3064-3064

2022

Volltextzugriff (PDF)

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v246-v247

2023

Volltextzugriff (PDF)

Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT064-CT064

2019

Volltextzugriff (PDF)

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2057-2057

2023

Volltextzugriff (PDF)

NCMP-07. CASE SERIES OF REGULARLY SCHEDULED MANNITOL INFUSIONS SHOWING WITH PROLONGED CLINICAL BENEFIT FOR MANAGEMENT OF CEREBRAL EDEMA IN GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii192-vii192

2022

Volltextzugriff (PDF)

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v221-v221

2023

Volltextzugriff (PDF)

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii240-vii240

2022

Volltextzugriff (PDF)

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v114-v114

2023

Volltextzugriff (PDF)

QOL-14. INTEGRATING A TECHNOLOGY-ENABLED PLATFORM FOR PATIENT REPORTED OUTCOMES INTO A NEURO-ONCOLOGY PRACTICE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v251-v251

2023

Volltextzugriff (PDF)

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v255-v255

2023

Volltextzugriff (PDF)

Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2550-2550

2023

Volltextzugriff (PDF)

Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E27-E28

2019

Volltextzugriff (PDF)

P12 - Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E27-E28

2019

Volltextzugriff (PDF)

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi76-vi76

2021

Volltextzugriff (PDF)

INNV-23. CASE REPORT OF CISPLATIN + ETOPOSIDE FOR THE TREATMENT OF METASTATIC MALIGNANT MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi110-vi110

2021

Volltextzugriff (PDF)

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii239-vii239

2022

Volltextzugriff (PDF)

CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii83-vii84

2022

Volltextzugriff (PDF)

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v76-v76

2023

Volltextzugriff (PDF)

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi140-vi140

2019

Volltextzugriff (PDF)

Using Cerebrospinal Fluid (CSF) tumor cells to track disease burden and treatment response in patients with Leptomeningeal Disease (LMD) from solid cancers (P13-9.006)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae110

2024

Volltextzugriff (PDF)

CTNI-32. CASE SERIES OF BRAF INHIBITORS FOR THE TREATMENT OF BRAFV600E GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi66-vi66

2021

Volltextzugriff (PDF)

BIOM-08. TARGETSELECTORTM CEREBROSPINAL FLUID (CSF) CIRCULATING TUMOR CELLS AND BIOMARKER ANALYSIS: IMPROVING SENSITIVITY AND TARGETED TREATMENT OPTIONS IN BREAST AND NSCLC CANCER PATIENTS WITH CNS INVOLVEMENT

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii3-ii3

2020

Volltextzugriff (PDF)

CTNI-46. PHASE I OPEN-LABEL, SINGLE-CENTER, DOSE ESCALATION STUDY (NCT02423525) OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi70-vi70

2021

Volltextzugriff (PDF)

Response to OKN-007 and NAC in a Patient with Unilateral Hearing Loss and Chronic Tinnitus from Vestibular Schwannoma

The international tinnitus journal, 2023-06, Vol.27 (1)

2023

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Berichte
(3)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Quality Improvement
(2)
Abstracts From The 20th Annual Scientific Meeting Of The Society For Neuro-Oncology
(1)
Accuracy
(1)
Adult
(1)
Aged
(1)
Aged, 80 And Over
(1)
Aids
(1)
Amino Acids
(1)
Astrocytoma - Diagnostic Imaging
(1)
Astrocytoma - Therapy
(1)
Bevacizumab
(1)
Biomarkers
(1)
Blood-Brain Barrier
(1)
Brain Cancer
(1)
Brain Neoplasms - Diagnostic Imaging
(1)
Brain Neoplasms - Therapy
(1)
Case Lesson
(1)
Case Report
(1)
Chemotherapy
(1)
Correction
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

NCMP-07. CASE SERIES OF REGULARLY SCHEDULED MANNITOL INFUSIONS SHOWING WITH PROLONGED CLINICAL BENEFIT FOR MANAGEMENT OF CEREBRAL EDEMA IN GLIOMAS

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

QOL-14. INTEGRATING A TECHNOLOGY-ENABLED PLATFORM FOR PATIENT REPORTED OUTCOMES INTO A NEURO-ONCOLOGY PRACTICE

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap

Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

P12 - Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

INNV-23. CASE REPORT OF CISPLATIN + ETOPOSIDE FOR THE TREATMENT OF METASTATIC MALIGNANT MENINGIOMA

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Using Cerebrospinal Fluid (CSF) tumor cells to track disease burden and treatment response in patients with Leptomeningeal Disease (LMD) from solid cancers (P13-9.006)

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

CTNI-32. CASE SERIES OF BRAF INHIBITORS FOR THE TREATMENT OF BRAFV600E GLIOBLASTOMA

BIOM-08. TARGETSELECTORTM CEREBROSPINAL FLUID (CSF) CIRCULATING TUMOR CELLS AND BIOMARKER ANALYSIS: IMPROVING SENSITIVITY AND TARGETED TREATMENT OPTIONS IN BREAST AND NSCLC CANCER PATIENTS WITH CNS INVOLVEMENT

CTNI-46. PHASE I OPEN-LABEL, SINGLE-CENTER, DOSE ESCALATION STUDY (NCT02423525) OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER

Response to OKN-007 and NAC in a Patient with Unilateral Hearing Loss and Chronic Tinnitus from Vestibular Schwannoma

Aktive Filter

Suchergebnisse filtern